Insider · CIK 0001256708

SHERMAN MARK ANDREW

Reports to the SEC for 3 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001256708

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-15	DLBDolby Laboratories, Inc.A Award	EVP, Gen. Counsel & Secretary	AAward	+48.1K sh	—	—	119,024
2025-12-17	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−2,491 sh	$67.26	−$168K	70,563
2025-12-16	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−2,371 sh	$67.17	−$159K	73,054
2025-12-16	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−6,738 sh	$66.58	−$449K	75,425
2025-12-16	DLBDolby Laboratories, Inc.F Tax Payment	EVP, Gen. Counsel & Secretary	FTax Payment	−2,530 sh	$66.62	−$169K	82,163
2025-12-15	DLBDolby Laboratories, Inc.F Tax Payment	EVP, Gen. Counsel & Secretary	FTax Payment	−9,252 sh	$67.54	−$625K	84,693
2025-12-15	DLBDolby Laboratories, Inc.M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	+5,915 sh	—	—	93,945
2025-12-15	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award	EVP, Gen. Counsel & Secretary	AAward	+56.4K sh	—	—	56,440
2025-12-15	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award	EVP, Gen. Counsel & Secretary	AAward	+12.8K sh	—	—	12,816
2025-12-15	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitM Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	−5,915 sh	—	—	0
2025-12-15	DLBDolby Laboratories, Inc.A Award	EVP, Gen. Counsel & Secretary	AAward	+25.6K sh	—	—	88,030
2025-12-01	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	−4,500 sh	—	—	0
2025-12-01	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−4,500 sh	$67.56	−$304K	62,397
2025-12-01	DLBDolby Laboratories, Inc.M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	+4,500 sh	$64.60	+$291K	66,897
2025-06-04	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	−15K sh	—	—	4,500
2025-06-04	DLBDolby Laboratories, Inc.M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	+15K sh	$64.60	+$969K	77,397
2025-06-04	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−15K sh	$75.02	−$1.13M	62,397
2025-05-30	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−350 sh	$74.97	−$26.2K	62,397
2025-01-30	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−25K sh	$86.00	−$2.15M	62,397
2025-01-30	DLBDolby Laboratories, Inc.M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	+40K sh	$62.32	+$2.49M	102,397
2025-01-30	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−15K sh	$83.00	−$1.25M	87,397
2025-01-30	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	−40K sh	—	—	16,000
2024-12-17	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−7,713 sh	$78.22	−$603K	62,397
2024-12-17	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−4,625 sh	$77.83	−$360K	70,110
2024-12-16	DLBDolby Laboratories, Inc.A Award	EVP, Gen. Counsel & Secretary	AAward	+20.1K sh	—	—	78,410
2024-12-16	DLBDolby Laboratories, Inc.M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	+5,192 sh	—	—	83,602
2024-12-16	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award	EVP, Gen. Counsel & Secretary	AAward	+10K sh	—	—	10,042
2024-12-16	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award	EVP, Gen. Counsel & Secretary	AAward	+35.3K sh	—	—	35,307
2024-12-16	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitM Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	−5,192 sh	—	—	0
2024-12-16	DLBDolby Laboratories, Inc.F Tax Payment	EVP, Gen. Counsel & Secretary	FTax Payment	−8,867 sh	$79.18	−$702K	74,735
2024-05-28	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	−1,998 sh	—	—	0
2024-05-28	DLBDolby Laboratories, Inc.M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	+1,998 sh	$62.32	+$125K	60,608
2024-05-28	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−2,283 sh	$79.62	−$182K	58,325
2023-12-19	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−1,663 sh	$86.01	−$143K	58,325
2023-12-18	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−8,856 sh	$86.19	−$763K	59,988
2023-12-18	DLBDolby Laboratories, Inc.F Tax Payment	EVP, Gen. Counsel & Secretary	FTax Payment	−1,637 sh	$87.49	−$143K	68,844
2023-12-15	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award	EVP, Gen. Counsel & Secretary	AAward	+8,363 sh	—	—	8,363
2023-12-15	DLBDolby Laboratories, Inc.F Tax Payment	EVP, Gen. Counsel & Secretary	FTax Payment	−8,713 sh	$88.60	−$772K	70,481
2023-12-15	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitM Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	−5,738 sh	—	—	0
2023-12-15	DLBDolby Laboratories, Inc.A Award	EVP, Gen. Counsel & Secretary	AAward	+16.7K sh	—	—	73,456
2023-12-15	DLBDolby Laboratories, Inc.M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	+5,738 sh	—	—	79,194
2023-12-15	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award	EVP, Gen. Counsel & Secretary	AAward	+29.3K sh	—	—	29,316
2023-07-12	DLBDolby Laboratories, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	−21K sh	—	—	1,998
2023-07-12	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−21K sh	$89.00	−$1.87M	56,730
2023-07-12	DLBDolby Laboratories, Inc.M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	+21K sh	$62.32	+$1.31M	77,730
2023-05-08	DLBDolby Laboratories, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	−3,882 sh	—	—	22,998
2023-05-08	DLBDolby Laboratories, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	−11.1K sh	—	—	0
2023-05-08	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−2,180 sh	$84.35	−$184K	56,374
2023-05-08	DLBDolby Laboratories, Inc.S Sale	EVP, Gen. Counsel & Secretary	SSale	−12.8K sh	$83.47	−$1.07M	58,554
2023-05-08	DLBDolby Laboratories, Inc.M Exercise/Conversion	EVP, Gen. Counsel & Secretary	MExercise/Conversion	+3,882 sh	$62.32	+$242K	71,374

Recent filings

Accepted (ET)
Sep 174
SHERMAN MARK ANDREW0001193125-26-394488
SEC(opens sec.gov)
Dec 174
SHERMAN MARK ANDREW0001193125-25-323425
SEC(opens sec.gov)
Dec 34
SHERMAN MARK ANDREW0001193125-25-307131
SEC(opens sec.gov)
Jun 64
SHERMAN MARK ANDREW0000950170-25-083386
SEC(opens sec.gov)
Jun 34
SHERMAN MARK ANDREW0000950170-25-081036
SEC(opens sec.gov)
Feb 34
SHERMAN MARK ANDREW0000950170-25-012643
SEC(opens sec.gov)

Companies

Address

C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET

SAN FRANCISCO, CA, 94103